BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 21921661)

  • 1. [Lymphatic neoplasias in young patients].
    Borchmann P; Gökbuget N; Wulf G; Trümper L
    Onkologie; 2011; 34 Suppl 5():6-11. PubMed ID: 21921661
    [No Abstract]   [Full Text] [Related]  

  • 2. [Autologous transplant with BEAM protocol in lymphoma].
    Caballero D; Rubio V; Rifon J; Heras I; García-Sanz R; Vidriales B; Pérez-Simón JA; del Cañizo C; González M; León A; Jean-Paul E; Rocha E; Vicente V; San Miguel JF
    Sangre (Barc); 1997 Apr; 42 Suppl 1():46-9. PubMed ID: 9381303
    [No Abstract]   [Full Text] [Related]  

  • 3. [The treatment results in children diagnosed with non-Hodgkin's lymphomas and acute B-cell lymphoblastic leukemias treated by the BFM protocols. The report of the POGM (Pediatric Oncology Group of Madrid)].
    Vivanco Martínez JL; López Pérez J; Melero Moreno C; Torres Valdivieso MJ; Palacios López ME; Contra Gómez T; Martín Ramos N; Bernacer Borja M; Gil López C; Valverde Moreno F
    An Esp Pediatr; 1998 Dec; 49(6):603-8. PubMed ID: 9972623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Controversies in therapy of malignant lymphomas].
    Diehl V; Engert A
    Internist (Berl); 1994 Apr; 35(4):313-22. PubMed ID: 8200756
    [No Abstract]   [Full Text] [Related]  

  • 5. [Medicinal therapy of malignant lymphomas].
    Aul C; Schroeder M; Giagounidis A
    Radiologe; 2002 Dec; 42(12):943-53. PubMed ID: 12486548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of maximum supportive care on dose compliance and survival. Single-center analysis of childhood acute lymphoblastic leukemia and non-Hodgkin's-lymphoma treated within 1984-1993.
    Urban C; Benesch M; Lackner H; Schwinger W; Kerbl R; Gadner H
    Klin Padiatr; 1997; 209(4):235-42. PubMed ID: 9293456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of the efficiency of CHOP-based regimen with or without high dose consolidation treatment combined with hematopoietic stem cell transplantation in 63 lymphoblastic lymphoma patients].
    Qin Y; Shi YK; He XH; Han XH; Zhou SY; Liu P; Yang JL; Yang S; Zhang CG; Dong M; Zhou LQ; Wang JW; Feng FY; Sun Y
    Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):469-73. PubMed ID: 19950562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lymphomas in adolescents: are childhood lymphoma therapy protocols suitable for this patient group?].
    Bence Z; Kovács G; Jakab Z; Csóka M; Müller J
    Magy Onkol; 2008 Dec; 52(4):357-62. PubMed ID: 19068463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of intensive post-remission chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia and lymphoblastic lymphoma: Japan Clinical Oncology Group Study, JCOG9402.
    Azuma T; Tobinai K; Takeyama K; Shibata T; Hidaka M; Kurosawa M; Kasai M; Chou T; Fukushima N; Mukai K; Tsukasaki K; Shimoyama M;
    Jpn J Clin Oncol; 2012 May; 42(5):394-404. PubMed ID: 22422899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemotherapy of malignant lymphomas].
    Oyama A; Ota K
    Gan No Rinsho; 1988 Apr; 34(5):565-71. PubMed ID: 3385922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-risk acute lymphoblastic leukemia (ALL): is there an alternative approach for increasing the number of cures?
    Carella AM
    Haematologica; 1992; 77(4):348-51. PubMed ID: 1358772
    [No Abstract]   [Full Text] [Related]  

  • 12. Adult acute leukemia.
    Hoelzer D; Büchner T; Gale RP; Zittoun R
    Rev Invest Clin; 1994 Apr; Suppl():21-5. PubMed ID: 7886303
    [No Abstract]   [Full Text] [Related]  

  • 13. Adult ALL: where are we and where are we going?
    Larson RA
    Clin Adv Hematol Oncol; 2004 Jun; 2(6):342-4. PubMed ID: 16163203
    [No Abstract]   [Full Text] [Related]  

  • 14. [Long-term follow-up of Hodgkin's disease and unfavorable type of non-Hodgkin's lymphoma].
    Sampi K; Maseki N; Sakurai M; Hattori M
    Rinsho Ketsueki; 1988 Feb; 29(2):144-8. PubMed ID: 3385941
    [No Abstract]   [Full Text] [Related]  

  • 15. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
    Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significant difference in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric vs adult protocols in the Netherlands.
    de Bont JM; Holt Bv; Dekker AW; van der Does-van den Berg A; Sonneveld P; Pieters R
    Leukemia; 2004 Dec; 18(12):2032-5. PubMed ID: 15483674
    [No Abstract]   [Full Text] [Related]  

  • 17. Double-delayed intensification paediatric protocol without radiotherapy is an efficient treatment in adult lymphoblastic lymphoma.
    Corre E; Marjanovic Z; Lapusan S; Vekhoff A; Hirsch P; Marie JP; Legrand O
    Hematol Oncol; 2012 Dec; 30(4):206-9. PubMed ID: 22271176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I/II study of high-dose cyclophosphamide, etoposide and cisplatin followed by autologous bone marrow or peripheral blood stem cell transplantation in patients with poor prognosis Hodgkin's disease or non-Hodgkin's lymphoma.
    Klumpp TR; Mangan KF; Glenn LD; Malaspina DR; Cropper T; Mullaney M; Macdonald JS
    Bone Marrow Transplant; 1993 Oct; 12(4):337-45. PubMed ID: 7506091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted therapy with monoclonal antibodies in acute lymphoblastic leukemia.
    Hoelzer D
    Curr Opin Oncol; 2013 Nov; 25(6):701-6. PubMed ID: 24097105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of ICE (ifosfamide-carboplatin-etoposide) versus DHAP (cytosine arabinoside-cisplatin-dexamethasone) as salvage chemotherapy in patients with relapsed or refractory lymphoma.
    Abali H; Urün Y; Oksüzoğlu B; Budakoğlu B; Yildirim N; Güler T; Ozet G; Zengin N
    Cancer Invest; 2008 May; 26(4):401-6. PubMed ID: 18443961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.